111 related articles for article (PubMed ID: 3064447)
1. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
Haberhauer G; Bröll H
Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
[TBL] [Abstract][Full Text] [Related]
2. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.
Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A
Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434
[TBL] [Abstract][Full Text] [Related]
3. [The value of using HEP/2 cells as compared to sections of rat liver in the detection of autoantibodies using indirect immunofluorescence in human pathology].
Makni S; Jenhani F; Ayed K
Rev Rhum Mal Osteoartic; 1989 Oct; 56(10):651-5. PubMed ID: 2512629
[TBL] [Abstract][Full Text] [Related]
4. [Decreased incidence of peripheral nuclear staining pattern by indirect immunofluorescent antibody technique using HEp-2 cells].
Miyawaki S; Asanuma H
Ryumachi; 1996 Aug; 36(4):644-50. PubMed ID: 8911082
[TBL] [Abstract][Full Text] [Related]
5. [Optimizing the clinical value of polyreactive autoantibodies to double-stranded DNA].
Haberhauer G; Chlud K; Isovits D
Z Gesamte Inn Med; 1989 Nov; 44(21):652-4. PubMed ID: 2692314
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma.
Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM
Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
Fritzler MJ
Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
[TBL] [Abstract][Full Text] [Related]
8. Studies of antinuclear antibodies in rheumatoid arthritis.
Garcia-de la Torre I; Miranda-Mendez L
J Rheumatol; 1982; 9(4):603-6. PubMed ID: 6182293
[TBL] [Abstract][Full Text] [Related]
9. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
10. [Detection of anti-nuclear antibodies and anti-cytoplasmic antibodies by immunofluorescence method using HEp-2 cells].
Moteki S; Kato Y; Ishikawa H; Honda S; Yoshida H; Sato K; Morito T
Rinsho Byori; 1989 May; 37(5):517-21. PubMed ID: 2671445
[No Abstract] [Full Text] [Related]
11. The detection of autoantibodies on HEp-2 cells using an indirect immunoperoxidase kit (Colorzyme).
Fritzler MJ; Wall W; Gohill J; Kinsella TD; Humbel RL
Diagn Immunol; 1986; 4(4):217-21. PubMed ID: 3530600
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
Dellen H; Seemayer NH
Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
[TBL] [Abstract][Full Text] [Related]
13. Nuclear matrix antibodies in rheumatic diseases.
Kurki P; Virtanen I; Lehto VP; Helve T
J Rheumatol; 1985 Apr; 12(2):253-6. PubMed ID: 3897532
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasmic staining pattern characteristic for anti Jo-1 antibody in HEp-2 cells].
Nagano Y; Yoshinoya S; Ohkubo A
Rinsho Byori; 1991 Mar; 39(3):269-72. PubMed ID: 1711130
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
[TBL] [Abstract][Full Text] [Related]
17. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms.
Goldblatt F; Beroukas D; Gillis D; Cavill D; Bradwell A; Rischmueller M; Gordon TP
J Rheumatol; 2000 Oct; 27(10):2382-8. PubMed ID: 11036834
[TBL] [Abstract][Full Text] [Related]
19. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
20. Anti-native DNA antibodies from autoimmune sera also bind to DNA in mitochondria.
Reimer G; Rubin RL; Kotzin BL; Tan EM
J Immunol; 1984 Nov; 133(5):2532-6. PubMed ID: 6384367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
